Scientific paper - Original scientific paper
Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?
World Journal of Diabetes, 11 (2020), 11; 540-552. https://doi.org/10.4239/wjd.v11.i11.540

Berković, Maja Cigrovski; Bilić Ćurčić, Ines; Božek, Tomislav; Mahecic, Davorka Herman; Klobučar Majanović, Sanja; Canecki-Varžić, Silvija; Andrić, Jelena; Marušic, Srećko; Mrzljak, Anna

Cite this document

Berković, M. C., Bilić Ćurčić, I., Božek, T., Mahecic, D. H., Klobučar Majanović, S., Canecki Varžić, S. ... Mrzljak, A. (2020). Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?. World Journal of Diabetes, 11. (11), 540-552. doi: 10.4239/wjd.v11.i11.540

Berković, Maja Cigrovski, et al. "Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?." World Journal of Diabetes, vol. 11, no. 11, 2020, pp. 540-552. https://doi.org/10.4239/wjd.v11.i11.540

Berković, Maja Cigrovski, Ines Bilić Ćurčić, Tomislav Božek, Davorka Herman Mahecic, Sanja Klobučar Majanović, Silvija Canecki Varžić, Jelena Andrić, Srećko Marušic and Anna Mrzljak. "Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?." World Journal of Diabetes 11, no. 11 (2020): 540-552. https://doi.org/10.4239/wjd.v11.i11.540

Berković, M. C., et al. (2020) 'Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?', World Journal of Diabetes, 11(11), pp. 540-552. doi: 10.4239/wjd.v11.i11.540

Berković MC, Bilić Ćurčić I, Božek T, Mahecic DH, Klobučar Majanović S, Canecki Varžić S, and sur.. Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?. World Journal of Diabetes [Internet]. 2020 November 15 [cited 2024 July 15];11(11):540-552. doi: 10.4239/wjd.v11.i11.540

M. C. Berković, et al., "Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?", World Journal of Diabetes, vol. 11, no. 11, pp. 540-552, November 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:215648. [Accessed: 15 July 2024]

Please login to the repository to save this object to your list.